Needham Starts CAMP4 Therapeutics Corp (CAMP) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq slides to near one-month low as AI rout deepens
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts CAMP Hot Sheet
Price: $3.49 +1.75%
Rating Summary:
17 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 31
Rating Summary:
17 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 31
Join SI Premium – FREE
Needham initiates coverage on CAMP4 Therapeutics Corp (NASDAQ: CAMP) with a Buy rating and a price target of $8.00.
For an analyst ratings summary and ratings history on CAMP4 Therapeutics Corp click here. For more ratings news on CAMP4 Therapeutics Corp click here.
Shares of CAMP4 Therapeutics Corp closed at $3.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia releases Nemotron 3.5 Super VL and Bolt edge models
- Dell Technologies (DELL) call put ratio 1 call to 1.3 puts as share price down 7.8%
- Rocket Lab USA, Inc. (RKLB) call put ratio 1.2 calls to 1 put as share price down 10.3%
Create E-mail Alert Related Categories
New CoverageRelated Entities
Needham & Company, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
